Clinical experience with stem cells and other cell therapies in neurological diseases. 2013

Dimitrios Karussis, and Panayiota Petrou, and Ibrahim Kassis
Department of Neurology, MS Center and Laboratory of Neuroimmunology, Agnes-Ginges Center for Neurogenetics, Hadassah University Hospital, Ein Kerem, Jerusalem, Israel. karus@cc.huji.ac.il

To overcome the limited capacity of the CNS for regeneration, the theoretical alternative would be to use stem cells for more effective management of chronic degenerative and inflammatory neurological conditions, and also of acute neuronal damage from injuries or cerebrovascular diseases. Although the adult brain contains small numbers of stem cells in restricted areas, this intrinsic stem cell repertoire is small and does not measurably contribute to functional recovery. Embryonic cells carrying pluripotent and self-renewal properties represent the stem cell prototype, but there are additional somatic stem cells that may be harvested and expanded from various tissues during adult life. Stem cell transplantation is based on the assumption that such cells may have the potential to regenerate or support the survival of the existing, partially damaged cells. This review summarizes the state-of-the-art and the clinical worldwide experience with the use of various types of stem cells in neurological diseases.

UI MeSH Term Description Entries
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D045164 Mesenchymal Stem Cell Transplantation Transfer of MESENCHYMAL STEM CELLS between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Stem Cell Transplantation, Mesenchymal,Transplantation, Mesenchymal Stem Cell
D033581 Stem Cell Transplantation The transfer of STEM CELLS from one individual to another within the same species (TRANSPLANTATION, HOMOLOGOUS) or between species (XENOTRANSPLANTATION), or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). The source and location of the stem cells determines their potency or pluripotency to differentiate into various cell types. Transplantation, Stem Cell,Stem Cell Transplantations,Transplantations, Stem Cell
D064987 Cell- and Tissue-Based Therapy Therapies that involve the TRANSPLANTATION of CELLS or TISSUES developed for the purpose of restoring the function of diseased or dysfunctional cells or tissues. Cell Therapy,Tissue Therapy,Therapy, Cell,Therapy, Tissue,Cell and Tissue Based Therapy

Related Publications

Dimitrios Karussis, and Panayiota Petrou, and Ibrahim Kassis
August 2008, Pulmonary pharmacology & therapeutics,
Dimitrios Karussis, and Panayiota Petrou, and Ibrahim Kassis
May 2019, Critical reviews in clinical laboratory sciences,
Dimitrios Karussis, and Panayiota Petrou, and Ibrahim Kassis
February 2006, Expert review of neurotherapeutics,
Dimitrios Karussis, and Panayiota Petrou, and Ibrahim Kassis
January 2009, ILAR journal,
Dimitrios Karussis, and Panayiota Petrou, and Ibrahim Kassis
November 2015, Trends in molecular medicine,
Dimitrios Karussis, and Panayiota Petrou, and Ibrahim Kassis
October 2007, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics,
Dimitrios Karussis, and Panayiota Petrou, and Ibrahim Kassis
February 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research,
Dimitrios Karussis, and Panayiota Petrou, and Ibrahim Kassis
February 2008, Cell proliferation,
Dimitrios Karussis, and Panayiota Petrou, and Ibrahim Kassis
June 2010, Discovery medicine,
Dimitrios Karussis, and Panayiota Petrou, and Ibrahim Kassis
October 2009, Transfusion medicine (Oxford, England),
Copied contents to your clipboard!